Vanderbilt Epidemiology Center
- Shanghai Cancer Institute, China
- The Shanghai Cancer Institute (SCI) was founded in 1958 and is an independent institution focused on cancer research affiliated with the Shanghai Municipal Bureau of Public Health. The SCI was identified by the WHO as a WHO Collaborating Centre for Research on Cancer in China in 1980. On the approval of the National Science and Technology Committee, the State Key Laboratory of Oncogenes and Related Genes (SKLORG) was established on the basis of the Department of Biochemistry and Molecular Biology in 1985. The Shanghai Research and Development Facilities for Gene Therapy with the GMP level was established within SCI in 1996, and the Cancer Institute of Shanghai Jiaotong University was approved by Chinese Ministry of Education in 2003. SCI’s mission is to conduct research on epidemiology, etiology, and mechanisms of chemical carcinogenesis of cancer to advance the comprehensive prevention and control of cancer.

